The evolving role of early-phase clinical trials reflects a broader truth: decisions made early carry increasing weight in ...
Phase 3 manufacturing campaign on track for completion no later than third quarter 2026, supporting expected pivotal trial in ...
Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in heparin-induced thrombocytopenia (HIT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results